Zhi-hang Zhou

High‐risk lymph node ratio predicts worse prognosis in patients with locally advanced oral cancer

Zhi-Yuan Zhang, Chen-ping Zhang, L. Zhong, 2020, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Overcoming chemotherapy resistance using pH-sensitive hollow MnO2 nanoshells that target the hypoxic tumor microenvironment of metastasized oral squamous cell carcinoma

Xiankun Cao, Xuzhuo Chen, L. Zhong, 2021, Journal of Nanobiotechnology.

Neoadjuvant chemo-free combination of camrelizumab and apatinib for locally advanced resectable oral squamous cell carcinoma – A pilot study

Ying-ying Huang, Qingwei Zhu, L. Zhong, 2021 .

A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma

Ying-ying Huang, L. Zhong, Yong Tang, 2022, Nature Communications.

Mechanism of sensitivity to cisplatin, docetaxel, and 5‐fluorouracil chemoagents and potential erbB2 alternatives in oral cancer with growth differentiation factor 15 overexpression

Zhi-Yuan Zhang, L. Zhong, TongChao Zhao, 2021, Cancer Science.

Anti-tumor effect of carrimycin on oral squamous cell carcinoma cells in vitro and in vivo

Yi-ran Tan, Zhi-Yuan Zhang, L. Zhong, 2021, Translational oncology.

Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial)

Y. Liu, Xiaoping Zhou, L. Zhong, 2023, International journal of surgery.

Combination of interferon-gamma and autophagy inhibitor as a therapeutic approach in oral squamous cell carcinoma

Zhi-Yuan Zhang, L. Zhong, Si-yuan Liang, 2020 .

A therapeutic approach with combination of interferon-gamma and autophagy inhibitor for oral squamous cell carcinoma.

Zhi-Yuan Zhang, L. Zhong, Si-yuan Liang, 2021, American journal of cancer research.

Targeting ERK combined with apatinib may be a promising therapeutic strategy for treating oral squamous cell carcinoma.

Zhi-Yuan Zhang, L. Zhong, Si-yuan Liang, 2021, American journal of cancer research.

Mechanism of sensitivity to cisplatin, docetaxel, and 5‐fluorouracil chemoagents and potential erbB2 alternatives in oral cancer with growth differentiation factor 15 overexpression

Zhi-Yuan Zhang, L. Zhong, Si-yuan Liang, 2021, Cancer science.